pharmacie et médicaments – Pénurie d'Androtardyl et frein à l'accès à la santé pour les hommes transgenres

This written question addresses the shortage of Androtardyl, a medication crucial for transgender men's healthcare. It highlights how this scarcity impedes access to essential health services and raises concerns about the adequacy of current pharmaceutical supply chains. The question seeks to understand the reasons behind the shortage and explore potential solutions to ensure consistent availability of this medication, impacting transgender individuals' well-being and healthcare rights.